The stock price of Medical Marijuana Inc (OTCMKTS:MJNA) continues to decline steadily over the past few months. Recently it declined below $0.10 on massive volume. It is one of the original marijuana stocks with a past of substantial gains in early 2013 as well as in 2014. However, this year has not brought any cheer for the company as the stock price continues with its downfall.
The beginning
Medical Marijuana belongs to the list of marijuana stocks that have been around in the industry since the beginning. It made a number of acquisitions in the growing cannabis market that drive future growth. The company’s most profitable segment is HempMeds. It is an exclusive master distributor that offers cannabidiol products manufactured from industrial hemp. Medical Marijuana’s products are already available in all fifty states and more than 40 nations. The distribution unit expects fast growing revenue and posted almost $2 million in sales in 3Q.
CanChew
The second important segment of Medical Marijuana is a joint venture firm, CanChew Biotechnologies that manufactures a hemp cannabidiol oil-infused chewing gum. The product has gained a considerable amount of media attention. It has been awarded with the “Triple Leaf Award” given by the HealthyLivinG Foundation.
The profile
Medical Marijuana Inc (OTCMKTS:MJNA) runs several segments that sell a diversified set of service and products in the cannabis and hemp market. The company holds stake in Wellness Managed Services, Canipa Holdings, HempMeds PX, Red Dice Holdings, CanChew Biotechnologies, HempVap™ and KannaLife Sciences. In first week of March, the company’s cannabis brands were showcased at Natural Products Expo West. Even if the medical cannabis products were not on the buying radar of the people, still they got an opportunity to know in detail about the products. It was a good marketing platform for the company where it highlighted the entire range of cannabis products.
